These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 2859278)
1. Drugs and the quality of life: the patient's point of view. Diamond R J Clin Psychiatry; 1985 May; 46(5 Pt 2):29-35. PubMed ID: 2859278 [TBL] [Abstract][Full Text] [Related]
2. Adherence to medication and quality of life in people with schizophrenia: results of a European multicenter study. Puschner B; Born A; Giessler A; Helm H; Leese M; Bindman JP; Gray RJ; Schene A; Kikkert M; Burti L; Marrella G; Becker T J Nerv Ment Dis; 2006 Oct; 194(10):746-52. PubMed ID: 17041286 [TBL] [Abstract][Full Text] [Related]
3. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects. Hofer A; Kemmler G; Eder U; Edlinger M; Hummer M; Fleischhacker WW J Clin Psychiatry; 2004 Jul; 65(7):932-9. PubMed ID: 15291682 [TBL] [Abstract][Full Text] [Related]
4. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012 [TBL] [Abstract][Full Text] [Related]
5. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia. Chino B; Nemoto T; Fujii C; Mizuno M Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107 [TBL] [Abstract][Full Text] [Related]
6. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication. Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893 [TBL] [Abstract][Full Text] [Related]
7. [Therapeutic treatment with neuroleptics. II: Subjective mechanisms of effect, compliance and consequences for treatment strategy]. Krausz M; Sorgenfrei T Psychiatr Prax; 1991 Jan; 18(1):14-20. PubMed ID: 1674155 [TBL] [Abstract][Full Text] [Related]
8. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia. Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237 [TBL] [Abstract][Full Text] [Related]
9. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence. Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133 [TBL] [Abstract][Full Text] [Related]
10. [Subjective well-being under antipsychotic treatment and its meaning for compliance and course of disease]. Naber D; Lambert M; Karow A Psychiatr Prax; 2004 Nov; 31 Suppl 2():S230-2. PubMed ID: 15586315 [TBL] [Abstract][Full Text] [Related]
11. Predictors of subjective and objective quality of life in outpatients with schizophrenia. Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437 [TBL] [Abstract][Full Text] [Related]
12. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia. Holzinger A; Loffler W; Muller P; Priebe S; Angermeyer MC J Nerv Ment Dis; 2002 Sep; 190(9):597-603. PubMed ID: 12357093 [TBL] [Abstract][Full Text] [Related]
13. Attitudes toward medication in inpatients with schizophrenia: a cluster analytic approach. Santone G; Rucci P; Muratori ML; Monaci A; Ciarafoni C; Borsetti G Psychiatry Res; 2008 Apr; 158(3):324-34. PubMed ID: 18262656 [TBL] [Abstract][Full Text] [Related]
14. Patterns of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia. Wehmeier PM; Kluge M; Schacht A; Helsberg K; Schreiber W; Schimmelmann BG; Lambert M J Psychiatr Res; 2008 Jul; 42(8):676-83. PubMed ID: 17720192 [TBL] [Abstract][Full Text] [Related]
15. The relationship between patient satisfaction and treatment outcomes in schizophrenia. Chue P J Psychopharmacol; 2006 Nov; 20(6 Suppl):38-56. PubMed ID: 17046986 [TBL] [Abstract][Full Text] [Related]
16. [Domain-specific subjective quality of life and illness-related limitations of chronic schizophrenic patients]. Lauer G; Stegmüller-Koenemund U Psychiatr Prax; 1994 Mar; 21(2):70-3. PubMed ID: 7910973 [TBL] [Abstract][Full Text] [Related]
17. Subjective well-being and initial dysphoric reaction under antipsychotic drugs - concepts, measurement and clinical relevance. Lambert M; Schimmelmann BG; Karow A; Naber D Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S181-90. PubMed ID: 14677077 [TBL] [Abstract][Full Text] [Related]
18. The long term--maximising potential for rehabilitation in patients with schizophrenia. Fagiolini A; Goracci A Eur Neuropsychopharmacol; 2007 Mar; 17 Suppl 2():S123-9. PubMed ID: 17336767 [TBL] [Abstract][Full Text] [Related]
19. Pharmacophilia and pharmacophobia: determinants of patients' attitudes towards antipsychotic medication. Sibitz I; Katschnig H; Goessler R; Unger A; Amering M Pharmacopsychiatry; 2005 May; 38(3):107-12. PubMed ID: 15902579 [TBL] [Abstract][Full Text] [Related]
20. [Therapeutic treatment with neuroleptics. I: State of research on mechanisms of action, effectiveness and compliance in treatment of psychoses]. Krausz M; Sorgenfrei T Psychiatr Prax; 1991 Jan; 18(1):9-13. PubMed ID: 1674156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]